BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 9.92
-0.08 (-0.80%)
Oct 15, 2026, 1:28 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 41.6 million as of October 14, 2026. It is the 41,250th most valuable company in the world and the 373rd biggest in Poland. Its market cap has decreased by 21.89% in one year.
Market Cap
41.60M
Enterprise Value
53.77M
Revenue
61.75M
Global Rank
Country Rank
#373 Poland
PE Ratio
52.37
ChartMarket Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 41.60M, an increase of 264.76%. That is a compound annual growth rate of 8.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 41.60M | -17.68% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.37B |
| NEUCA | 3.18B |
| Synektik Spólka Akcyjna | 3.03B |
| Voxel | 1.54B |
| Read-Gene | 59.42M |
| Biogened | 48.88M |
| Genomtec | 45.12M |
| MedApp | 45.02M |